Advertisement Chiltern signs partnership agreement with EPS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Chiltern signs partnership agreement with EPS

Chiltern International, a global clinical research organization, has entered into a global partnership agreement with EPS International, a subsidiary of clinical development services provider EPS.

Under the agreement, Chiltern will provide services to EPS International from its network of offices in 23 countries throughout Europe, North America, South America and India. Similarly, EPS will provide clinical development services for the Asian region from their offices in Japan, China, Singapore, Korea and Taiwan.

Glenn Kerkhof, CEO of Chiltern, said: “Asia is becoming an increasingly attractive market for clinical trial services and finding a partner with a meaningful presence and experience of conducting clinical trials throughout Southeast Asia is an important development for Chiltern.

“With EPS as our partner in this region we continue to focus on our mission to deliver expert, high quality, clinical development services around the world.”